The COVID-19 pandemic: a threat to antimicrobial resistance containment-Reference-Cited by-同舟云学术

The COVID-19 pandemic: a threat to antimicrobial resistance containment

Published:2021-09 Issue:8 Volume:7 Page:
ISSN:2056-5623
Container-title:Future Science OA
language:en
Short-container-title:Future Science OA

Author:

Founou Raspail C¹²³^ORCID,Blocker Ariel J³⁴^ORCID,Noubom Michel¹⁵,Tsayem Cedrice⁶,Choukem Siméon P²⁷^ORCID,Dongen Maarten Van³⁸^ORCID,Founou Luria L³⁹^ORCID

Affiliation:

1. Department of Microbiology, Hematology & Immunology, Faculty of Medicine & Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon

2. United COVID-19 TaskForce, University of Dschang, Dschang, Cameroon

3. AMR Insights Ambassador Network, Amsterdam, The Netherlands

4. Evotec ID Lyon, Severe Bacterial Infections Unit & Bacteriology/Bacteriomics Platform Lyon, France

5. District Hospital of Dschang, Dschang, Cameroon

6. Department of Clinical Biochemistry, Centre of Expertise & Biological Diagnostic of Cameroon, Yaoundé, Cameroon

7. Department of Internal Medicine & Specialties, Faculty of Medicine & Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon

8. AMR Insights, Amsterdam, The Netherlands

9. Department of Food Safety & Environmental Microbiology, Centre of Expertise & Biological Diagnostic of Cameroon, Yaoundé, Cameroon

Abstract

As of 23 April 2021, the outbreak of COVID-19 claimed around 150 million confirmed cases with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of antimicrobial resistance (AMR), is likely complicating the outcome of COVID-19 patients. This study discusses the current knowledge on the emergence of the SARS-CoV-2 and highlights the likely contribution of the COVID-19 pandemic on the escalation of AMR. COVID-19 engenders extensive antibiotic overuse and misuse, and will undoubtedly and substantially increase AMR rates worldwide. Amid the expanding COVID-19 pandemic, policymakers should consider the hidden threat of AMR much more, which may well be enhanced through improper use of antibiotics to treat patients with severe COVID-19 infection.

Publisher

Future Science Ltd

Subject

Biotechnology

Link

https://www.future-science.com/doi/pdf/10.2144/fsoa-2021-0012

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, characterization, molecular docking studies and biological evaluation of 5, 6, 7, 8-tetrahydropyrido[3,4-d]pyrimidine derivatives as antimicrobial agents;Chemical Data Collections;2024-10

2. Microencapsulation of Origanum heracleoticum L. and Thymus vulgaris L. essential oils – Novel strategy to combat multi-resistant Acinetobacter baumannii;Industrial Crops and Products;2024-09

3. Review on antibiotic pollution dynamics: insights to occurrence, environmental behaviour, ecotoxicity, and management strategies;Environmental Science and Pollution Research;2024-08-19

4. RIGHT SEPSIS CLASSIFICATION- MUST FOR ANTIMICROBIAL STEWARDSHIP: A LONGITUDINAL OBSERVATIONAL STUDY;2024-08-07

5. The pharmacists’ interventions after a Drug and Therapeutics Committee (DTC) establishment during the COVID-19 pandemic;Journal of Pharmaceutical Policy and Practice;2024-07-12